Table 1.
Clinical diagnosis | PMCA positive/total samples analyzed |
---|---|
sCJD MM1 | 5/24 |
sCJD MV1 | 0/8 |
sCJD VV1 | 3/3 |
sCJD MM2 | 0/16 |
sCJD MV2 | 5/11 |
sCJD VV2 | 16/19 |
sCJD all types | 29/81 |
Other neurological diseases | 0/94 |
Healthy controls | 0/66 |
Clinical diagnosis | PMCA positive/total samples analyzed |
---|---|
sCJD MM1 | 5/24 |
sCJD MV1 | 0/8 |
sCJD VV1 | 3/3 |
sCJD MM2 | 0/16 |
sCJD MV2 | 5/11 |
sCJD VV2 | 16/19 |
sCJD all types | 29/81 |
Other neurological diseases | 0/94 |
Healthy controls | 0/66 |